Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Patent Suit Or Smear Campaign? Automated Pap Firms Raise Legal Stakes

This article was originally published in The Gray Sheet

Executive Summary

TriPath accuses Cytyc of unlawful business interference in an unfair competition/patent infringement lawsuit filed June 17

You may also be interested in...

Digene Physician Detailing Pact With PDI Tops DNAwithPap Launch Strategy

Digene does not plan to extend a co-promotion pact with Cytyc for its DNAwithPap test after signing on PDI to set up a U.S. physician detailing organization

TriPath Expanded Pap Labeling Data Claim Closes Gap With Cytyc

TriPath expects narrower price differences between its SurePath and Cytyc's ThinPrep Pap test alternative over the long-term after receiving FDA sign-off on labeling that puts the tests on par for efficacy

Digene SurePath “Not-Approvable” Letter Expected After FDA Data Request

Digene will be required to submit additional clinical data to FDA to support its application for use of TriPath's SurePath test pack as a specimen collection medium for the Hybrid Capture 2 (HC2) human papillomavirus (HPV) test

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts